Review article: Iron and inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 4, 2001, Pages 429-438

  Oldenburg, B ^a   Koningsberger, J C ^a   Van Berge Henegouwen, G P ^a   Van Asbeck, B S ^a,b   Marx, J J M ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; HEMOGLOBIN; IRON; REACTIVE OXYGEN METABOLITE; TRANSFERRIN; TRANSFERRIN RECEPTOR; FERRITIN;

CHRONIC DISEASE; DISEASE ASSOCIATION; ENTERITIS; ERYTHROPOIESIS; HUMAN; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON THERAPY; IRON TRANSPORT; NONHUMAN; PRIORITY JOURNAL; REVIEW; DIET SUPPLEMENTATION; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; ERYTHROPOIETIN; FERRITINS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; RECEPTORS, TRANSFERRIN;

EID: 0035072594     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00930.x     Document Type: Review

References (97)

1. Ascorbic acid: A factor concentrated in human gastric juice
2. Characterization and partial purification of a ferrireductase from human duodenal microvillus membranes
3. Complex formation, polymerization, and autoreduction in the ferric fructose system
4. Regulation of metal absorption in the gastrointestinal tract
5. A concise review: Iron absorption - The mucin-mobilferrin-integrin pathway. A competitive pathway for metal absorption
6. A newly identified iron binding protein in duodenal mucosa of rats. Purification and characterization of mobilferrin
7. Nutritional and physiologic significance of metallothionein
8. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
9. Cloning and characterization of a mammalian proton-coupled metal-ion transporter
10. Duodenal metal transporter (DMT-1. NRAMP-2) expression in patients with hereditary haemochromatosis
11. Adaptive response of iron absorption to anemia, increased erythropoiesis, iron deficiency and iron loading in beta2-microglobulin knockout mice
12. Competitive advantage of diferric transferrin in delivering iron to reticulocytes
13. Evidence for a humoral factor influencing iron absorption
14. Increase of the protein apoferritin in the gastrointestinal tract mucosa as a direct response to iron feeding: The function of ferritin in the regulation of iron absorption
15. Molecular cloning and characterisation of a novel duodenal-specific gene implicated in iron absorption
16. Oxygen toxicity, oxygen radicals, transition metals and disease
17. Iron-responsive elements: Regulatory RNA sequences that control mRNA levels and translation
18. Regulating the fate of mRNA: The control of cellular iron metabolism
19. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
20. Malnutrition and malabsorption in Crohn's disease with reference to the effect of surgery
21. Decreased iron absorption in patients with active rheumatoid arthritis, with and without iron deficiency
22. Does active rheumatoid arthritis affect intestinal iron absorption?
23. Iron absorption and serum ferritin in chronic inflammatory bowel disease
24. The anemia of chronic disorders
25. Anemia of chronic disease
26. The anaemia of chronic disorders
27. Iron, infections, and anemia of inflammation
28. The anemia of infection: Experimental production of hypoferremia and anaemia in dogs
29. Blocking of iron absorption by a preliminary oral dose of iron
30. Phase I study of recombinant tumor necrosis factor in cancer patients
31. Phase I trial of recombinant interferon gamma in cancer patients
32. Effect of inflammatory cytokines on hypoxia-induced erythropoeitin production
33. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys
34. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency
35. Inhibition of erytrhoid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease
36. Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells
37. In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection
38. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines 1L-4 and 1L-13
39. New insights into the pathogenesis of anemia of chronic diseases: Induction of ferritin synthesis and development of anemia during recombinant human interleukin- 10 (rHuIL- 10) treatment of chronic active Crohn's disease
40. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway
41. Iron and anemia of chronic disease
42. Mechanisms of iron acquisition and bacterial virulence
43. Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload
44. Role of iron in the pathogenesis of Vibrio vulnificus infections
45. Inhibition of the growth of Neisseria meningitides by reduced ferritin and other iron-binding agents
46. The role of iron overload in Yersirda enterocolica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients
47. The etiology of the anemia of chronic disease and infection
48. Increased incidence of gram-negative neonatal sepsis with intramuscular iron administration
49. Intramuscular iron-dextran and susceptibility of neonates to bacterial infections. In vitro studies
50. Effect of iron prophylaxis on morbidity due to infectious disease: Report on clinical studies in Papua New Guinea
51. Starvation suppression and refeeding activation of infection; an ecological necessity?
52. An ecological interdependence of diet and disease? A study of infection in one tribe consuming two different diets
53. Long-term developmental outcome of infants with iron deficiency
54. Oxidants and free radicals in inflammatory bowel disease
55. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease. Cause, consequence or epiphenomenon?
56. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: Toxins, mediators, and modulators of gene expression
57. Oxygen radicals and human disease
58. Reactive oxygen species, lipid peroxides, and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus
59. Reperfusion injury after myocardial infarction: The role of free radicals and the inflammatory response
60. Ageing and free radicals
61. The Fenton reaction
62. NF-κB and rel proteins in innate immunity
63. Role of transcription factor Nf-κB/Rel in induction of nitric oxide synthase
64. Nuclear Factor-κB: A pivotal transcription factor in chronic inflammatory diseases
65. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
66. Iron primes hepatic macrophages for NF-κB activation in alcoholic liver injury
67. Nutrition and metabolism of the trace elements
68. Iron and lymphocytes: Reciprocal regulatory interactions
69. Role of iron in T cell activation: Th1 clones differ from Th2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine
70. Iron differentially modulates the CD4-lck and CD8-lck complexes in resting peripheral blood T-lymphocytes
71. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity
72. Decreased concentrations of tumor necrosis factor-α in supernatants of monocytes from homozygotes for hereditary haemochromatosis
73. Iron regulates nitric oxide synthase activity by controlling nuclear transcription
74. Clinical evaluation of iron deficiency
75. A clinical evaluation of serum ferritin as an index of iron stores
76. Iron deficiency: Definition and diagnosis
77. Production of the serum form of the transferrin receptor by a cell membrane-associated serine protease
78. Serum transferrin receptor: A quantitative measure of tissue iron deficiency
79. New tools for clinical evaluation of erythron function in man
80. Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum
81. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia
82. Serum transferrin receptor/ferritin ratio is a reliable predictor of iron deficiency anemia in inflammatory bowel disease patients
83. Is serum transferrin receptor useful for detecting iron-deficiency in anaemic patients with chronic inflammatory diseases?
84. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease
85. Intravenous iron and erythropoietin for anemia associated with Crohn's disease
86. Free radicals and the etiology of colon cancer
87. The adverse effect of intravenous iron-dextran in rheumatoid arthritis
88. The importance of iron in rheumatoid disease
89. Effect of intravenous iron dextran on rheumatoid synovitis
90. Enhancement by dietary iron of lipid peroxidation in mouse colon
91. Iron supplementation generates hydroxyl radical in vivo. An ESR spintrapping investigation
92. Iron supplementation affects the produciton of proinflammatory cytokines in IL-10 deficient mice
93. Iron supplementation may aggrevate inflammatory status of colitis in a rat model
94. Effect of dietary iron supplementation on intestinal inflammation and oxidative stress in rats with induced colitis
95. Iron load and its effects on oxidative stress and inflammation in rats with induced colitis
96. Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats